GC WellBeing

녹십자웰빙 · 234690

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$116.1M (₩160.2B)

Overview

GC WellBeing makes injectable vitamins, minerals, and specialty prescription drugs, such as a human placenta extract and a tissue-regenerating pain-relief injection, that clinics and hospitals administer directly to patients.

It also supplies a clinic-exclusive line of oral health supplements, including vitamins and probiotics, under the Dr.PNT brand, as well as aesthetic medical devices such as skin boosters and fillers. Listed on KOSDAQ, Korea's tech and small-cap board, its prescription injectable nutrition products form the core of its business, with clinics and pharmaceutical wholesalers as its primary distribution channels.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$119.3M
▲ +23.1% YoY
Operating profit · FY2025
US$12.5M
▲ +33.4% YoY
Net income · FY2025
US$7.3M
▲ +41.6% YoY

Revenue

  • FY2023US$87.3M
  • FY2024US$97M
  • FY2025US$119.3M

Operating profit

  • FY2023US$7.6M
  • FY2024US$9.4M
  • FY2025US$12.5M

Net income

  • FY2023US$4.9M
  • FY2024US$5.1M
  • FY2025US$7.3M

Key ratios (FY2025)

ROE
8.9%
Debt/Eq
97.2%
Op. margin
10.5%
Net margin
6.1%
Rev. YoY
▲ +23.1%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.